162 related articles for article (PubMed ID: 12542574)
1. Magnetic resonance imaging, Down's syndrome and Alzheimer's disease: research and clinical implications.
Prasher V; Cumella S; Natarajan K; Rolfe E; Shah S; Haque MS
J Intellect Disabil Res; 2003 Feb; 47(Pt 2):90-100. PubMed ID: 12542574
[TBL] [Abstract][Full Text] [Related]
2. Diagnosing dementia in adults with Down's syndrome.
Prasher VP; Sachdeva N; Tarrant N
Neurodegener Dis Manag; 2015; 5(3):249-56. PubMed ID: 26107323
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease and Down's syndrome: an in vivo MRI study.
Beacher F; Daly E; Simmons A; Prasher V; Morris R; Robinson C; Lovestone S; Murphy K; Murphy DG
Psychol Med; 2009 Apr; 39(4):675-84. PubMed ID: 18667098
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging analysis of age-related changes in the brains of individuals with Down's syndrome.
Kesslak JP; Nagata SF; Lott I; Nalcioglu O
Neurology; 1994 Jun; 44(6):1039-45. PubMed ID: 8208396
[TBL] [Abstract][Full Text] [Related]
5. MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia.
Aylward EH; Li Q; Honeycutt NA; Warren AC; Pulsifer MB; Barta PE; Chan MD; Smith PD; Jerram M; Pearlson GD
Am J Psychiatry; 1999 Apr; 156(4):564-8. PubMed ID: 10200735
[TBL] [Abstract][Full Text] [Related]
6. A case of Down's syndrome with diffuse Lewy body disease and Alzheimer's disease.
Bodhireddy S; Dickson DW; Mattiace L; Weidenheim KM
Neurology; 1994 Jan; 44(1):159-61. PubMed ID: 8290054
[TBL] [Abstract][Full Text] [Related]
7. MRI brain changes in subjects with Down syndrome with and without dementia.
Pearlson GD; Breiter SN; Aylward EH; Warren AC; Grygorcewicz M; Frangou S; Barta PE; Pulsifer MB
Dev Med Child Neurol; 1998 May; 40(5):326-34. PubMed ID: 9630260
[TBL] [Abstract][Full Text] [Related]
8. Brain anatomy and ageing in non-demented adults with Down's syndrome: an in vivo MRI study.
Beacher F; Daly E; Simmons A; Prasher V; Morris R; Robinson C; Lovestone S; Murphy K; Murphy DG
Psychol Med; 2010 Apr; 40(4):611-9. PubMed ID: 19671216
[TBL] [Abstract][Full Text] [Related]
9. Serum amyloid A protein, albumin and prealbumin in Alzheimer's disease and in demented patients with Down's syndrome.
Elovaara I; Maury CP; Palo J
Acta Neurol Scand; 1986 Sep; 74(3):245-50. PubMed ID: 2947417
[TBL] [Abstract][Full Text] [Related]
10. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H
Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261
[TBL] [Abstract][Full Text] [Related]
11. Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.
Sabbagh MN; Chen K; Rogers J; Fleisher AS; Liebsack C; Bandy D; Belden C; Protas H; Thiyyagura P; Liu X; Roontiva A; Luo J; Jacobson S; Malek-Ahmadi M; Powell J; Reiman EM
Alzheimers Dement; 2015 Aug; 11(8):994-1004. PubMed ID: 25849033
[TBL] [Abstract][Full Text] [Related]
12. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing.
van Gool WA; Evenhuis HM; van Duijn CM
Ann Neurol; 1995 Aug; 38(2):225-30. PubMed ID: 7654070
[TBL] [Abstract][Full Text] [Related]
13. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.
Krasuski JS; Alexander GE; Horwitz B; Rapoport SI; Schapiro MB
Am J Psychiatry; 2002 Jan; 159(1):74-81. PubMed ID: 11772693
[TBL] [Abstract][Full Text] [Related]
14. PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).
Rafii MS; Lukic AS; Andrews RD; Brewer J; Rissman RA; Strother SC; Wernick MN; Pennington C; Mobley WC; Ness S; Matthews DC;
J Alzheimers Dis; 2017; 60(2):439-450. PubMed ID: 28946567
[TBL] [Abstract][Full Text] [Related]
15. Comparative investigation of neurofibrillary damage in the temporal lobe in Alzheimer's disease, Down's syndrome and dementia pugilistica.
McKenzie JE; Roberts GW; Royston MC
Neurodegeneration; 1996 Sep; 5(3):259-64. PubMed ID: 8910904
[TBL] [Abstract][Full Text] [Related]
16. Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology.
Margallo-Lana ML; Moore PB; Kay DW; Perry RH; Reid BE; Berney TP; Tyrer SP
J Intellect Disabil Res; 2007 Jun; 51(Pt. 6):463-77. PubMed ID: 17493029
[TBL] [Abstract][Full Text] [Related]
17. Dementia in Down's syndrome: cerebral glucose utilization, neuropsychological assessment, and neuropathology.
Schapiro MB; Ball MJ; Grady CL; Haxby JV; Kaye JA; Rapoport SI
Neurology; 1988 Jun; 38(6):938-42. PubMed ID: 2966900
[TBL] [Abstract][Full Text] [Related]
18. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
[TBL] [Abstract][Full Text] [Related]
19. Down's syndrome and Alzheimer's disease.
Sigal MJ; Levine N
J Can Dent Assoc; 1993 Oct; 59(10):823-5, 829. PubMed ID: 8221282
[TBL] [Abstract][Full Text] [Related]
20. Down syndrome, Alzheimer's disease and seizures.
Menéndez M
Brain Dev; 2005 Jun; 27(4):246-52. PubMed ID: 15862185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
